In NSCLC, the activation of the EMT program has been associated with epithelial growth factor receptor (EGFR)-TKI resistance [40], and different strategies have been devised to interfere with TGFβ-induced EMT. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.